# Horizon Discovery

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/horizon-discovery

- Industry: Biotechnology
- Headquarters: Cambridge, UK
- Website: www.horizondiscovery.com
- Total disclosed funding: $26M
- Latest round: Series C (May 30, 2013)
- Investors on record: 7

## About

Horizon Discovery Ltd. is a biotechnology company that specializes in gene editing and modulation solutions, providing innovative tools and services for functional genomics research.Founded in 2005 and headquartered in Cambridge, UK, Horizon Discovery Ltd. focuses on gene editing technologies. The company has raised GBP 68.8 million through its IPO on the AIM of the London Stock Exchange on March 24, 2014. The CEO is Terry Pizzie.Horizon Discovery Ltd. offers a comprehensive suite of advanced gene editing and modulation solutions. Their key products include Pin-point™ Base Editing Reagents and a variety of Dharmacon™ Reagents, which support precise gene editing using CRISPR technology and RNA interference. These offerings cater to clients in academia, biotechnology, and pharmaceuticals engaged in genomic research, and are marketed primarily in North America, Europe, and parts of Asia.For the year 2020, Horizon Discovery Ltd. reported a revenue of GBP 0. In 2023, the company's EBITDA was GBP -887,788.7.Horizon Discovery Ltd. aims to expand its product line with new offerings in gene editing technologies set for launch in the coming fiscal year. The company plans to penetrate additional markets in Asia and expand its presence in North America by 2025. The recent funding of GBP 68.8 million raised in its IPO will support these initiatives, with a focus on research and development and market expansion efforts.

## Funding rounds

- Series C, May 30, 2013, $9.9M — Molten Ventures, MVM Partners, Cambridge Enterprise, Calculus Capital, Roche Venture Fund, Wren Capital, Providence Investment Company
- Series C, Sep 15, 2011, $8M — Molten Ventures, MVM Partners, Roche Venture Fund
- Series C, Sep 23, 2010, $7.4M — Molten Ventures, Roche Venture Fund
- Series A, Mar 18, 2008, $0.3M — Cambridge Enterprise
- Seed, Jul 12, 2007 — Cambridge Enterprise

## Investors

- Cambridge Enterprise — Seed, Series A, Series C
- Molten Ventures (https://capitalatlas.ai/funds/molten-ventures) — Series C
- Roche Venture Fund (https://capitalatlas.ai/funds/roche-venture-fund) — Series C
- MVM Partners (https://capitalatlas.ai/funds/mvm-partners) — Series C
- Calculus Capital (https://capitalatlas.ai/funds/calculus-capital) — Series C
- Wren Capital (https://capitalatlas.ai/funds/wren-capital) — Series C
- Providence Investment Company — Series C